China Resources Pharmaceutical Group Ltd historical data
| Date | Open | High | Low | Close | Adj. close | Volume |
|---|---|---|---|---|---|---|
| 2026-10-20 | 4.685 | 4.755 | 4.630 | 4.655 | 4.655 | 9,880,500 |
| 2026-10-16 | 4.710 | 4.725 | 4.600 | 4.605 | 4.605 | 7,532,028 |
| 2026-10-15 | 4.605 | 4.715 | 4.565 | 4.710 | 4.710 | 16,109,099 |
| 2026-10-14 | 4.500 | 4.630 | 4.440 | 4.620 | 4.620 | 13,392,500 |
| 2026-10-13 | 4.410 | 4.500 | 4.330 | 4.500 | 4.500 | 7,433,365 |
| 2026-10-12 | 4.380 | 4.415 | 4.360 | 4.375 | 4.375 | 6,357,148 |
| 2026-10-09 | 4.360 | 4.400 | 4.290 | 4.380 | 4.380 | 4,783,538 |
| 2026-10-08 | 4.385 | 4.385 | 4.310 | 4.340 | 4.340 | 6,699,984 |
| 2026-10-07 | 4.340 | 4.340 | 4.255 | 4.290 | 4.290 | 4,335,280 |
| 2026-10-06 | 4.300 | 4.345 | 4.300 | 4.320 | 4.320 | 1,261,118 |
| 2026-10-05 | 4.260 | 4.305 | 4.225 | 4.305 | 4.305 | 3,273,000 |
| 2026-10-02 | 4.400 | 4.425 | 4.265 | 4.295 | 4.295 | 4,782,500 |
| 2026-09-30 | 4.380 | 4.470 | 4.345 | 4.450 | 4.450 | 9,132,126 |
| 2026-09-29 | 4.325 | 4.405 | 4.325 | 4.360 | 4.360 | 6,317,000 |
| 2026-09-28 | 4.290 | 4.360 | 4.290 | 4.355 | 4.355 | 5,225,000 |
| 2026-09-25 | 4.285 | 4.305 | 4.230 | 4.295 | 4.295 | 1,517,646 |
| 2026-09-24 | 4.365 | 4.365 | 4.290 | 4.330 | 4.330 | 5,820,000 |
| 2026-09-23 | 4.375 | 4.375 | 4.335 | 4.365 | 4.365 | 4,406,750 |
| 2026-09-22 | 4.400 | 4.400 | 4.320 | 4.325 | 4.325 | 4,252,000 |
| 2026-09-21 | 4.335 | 4.395 | 4.310 | 4.380 | 4.380 | 11,264,687 |
Page 1 of 1 · 20 trading days
Stock splits
No stock splits on record.
Dividends
| Ex-date | Amount |
|---|---|
| 2026-09-10 | 0.1006 HKD |
| 2026-06-17 | 0.1390 HKD |
| 2025-09-11 | 0.0789 HKD |
| 2025-05-28 | 0.0560 HKD |
| 2024-09-10 | 0.0908 HKD |
| 2024-06-04 | 0.1697 HKD |
| 2023-06-05 | 0.1600 HKD |
| 2022-06-06 | 0.1500 HKD |
| 2021-06-02 | 0.1200 HKD |
| 2020-06-29 | 0.1100 HKD |
| 2020-06-03 | 0.1100 HKD |
| 2019-06-03 | 0.1300 HKD |
Open, high, low and close are as traded (HKD). Adjusted close accounts for splits and dividends. Educational only, not financial advice.